Founders Financial Alliance’s Antares Pharma, Inc. ATRS Stock Holding History

Founders Financial Alliance’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,500	Closed	-$47K	–	550
2022 Q1	$47K	Hold	11,500	–	–	0.02%	329
2021 Q4	$41K	Hold	11,500	–	–	0.02%	367
2021 Q3	$42K	Hold	11,500	–	–	0.02%	340
2021 Q2	$50K	Buy	11,500 +1,500	+15%	+$6.11K	0.02%	347
2021 Q1	$41K	Hold	10,000	–	–	0.02%	343
2020 Q4	$40K	Sell	10,000 -632	-6%	-$2.04K	0.02%	305
2020 Q3	$215K	Buy	+10,632	New	+$29.4K	0.13%	146

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Founders Financial Alliance's ATRS Position: Q2 2022 in Review

Founders Financial Alliance sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 11,500 shares — an estimated $47K sold.

Founders Financial Alliance first reported a position in ATRS in Q3 2020 and held it in 7 quarters. The position peaked at $215K in Q3 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Founders Financial Alliance reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Founders Financial Alliance sold 11,500 Antares Pharma, Inc. shares in Q2 2022, an estimated $47K.
Founders Financial Alliance first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 7 quarters.
Founders Financial Alliance's Antares Pharma, Inc. position peaked at $215K in Q3 2020.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Founders Financial Alliance's 13F filing for Q2 2022, filed 15 Aug 2022.